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 Abstract 
 Genetic recombination in positive-strand RNA viruses is a significant evolutionary 25 
mechanism which drives the creation of viral diversity by formation of novel chimeric 
genomes. The process and its consequences, for example the generation of viruses with 
novel phenotypes, has been historically studied by analysis of the end products. More 
recently, with an appreciation that there are both replicative and non-replicative mechanisms 
at work, and with new approaches and techniques to analyse intermediate products, the 30 
viral and cellular factors that influence the process are becoming understood. The major 
influence on replicative recombination is the fidelity of viral polymerase, though RNA 
structures and sequence may also have an impact. In replicative recombination the viral 
polymerase is necessary and sufficient, though roles for other viral or cellular proteins may 
exist. In contrast, non-replicative recombination appears mediated solely by cellular 35 
components. Despite these insights, the relative importance of replicative and non-
replicative mechanisms is not clear. Using single-stranded, positive sense, RNA viruses as 
exemplars we review the current state of understanding of the processes and consequences 
of recombination. 
 40 
Introduction 
RNA viruses are ubiquitous in nature as a consequence of their ability to evolve 
rapidly and to adapt to new environments. This rapid evolution, in turn, is partly dependent 
upon the high levels of genetic diversity that are a hallmark of RNA virus populations. This 
diversity primarily arises from the error prone nature of the viral RNA-dependent RNA 45 
polymerases (RdRp). During genome replication these introduce substitutions, insertions 
and deletions and typically exhibit error rates of 10-3 to 10-5 per nucleotide polymerized [1]. 
However, much larger scale variation can be introduced into the virus population through 
the analogous processes of reassortment in the segmented RNA viruses, and 
recombination, which can occur in both the segmented and non-segmented RNA virus 50 
families. To generate viable hybrid progeny, both reassortment and recombination require 
the co-infection of a single cell with compatible genomes. However, reassortment occurs as 
a result of the exchange of discrete segments during genome packaging into nascent 
particles ([2], and reviewed in [3]), while recombination results in the formation of genetic 
hybrids within the genomic segment by fundamentally different mechanistic processes.  55 
A role for recombination in driving genetic diversity has been known for almost 100 
years [4], but the ability of RNA viruses to exchange genetic material via recombination was 
 only discovered  relatively recently. However, what is clear is that recombination is primarily 
a process of positive-strand RNA viruses and is observed very rarely in the negative-strand 
viruses (reviewed in [5]). For this reason, this review focuses on the single-stranded positive-60 
sense RNA viruses. The first experimental evidence of recombination in these viruses arose 
from studies in poliovirus [6-8], but has since been shown to occur in a wide range of 
positive-sense RNA viruses [9-11], infecting all types of organisms from humans and 
animals, to plants and bacteria [12-14]. It seems likely that recombination is ubiquitous in 
the positive-strand RNA viruses. 65 
 
Virus Evolution and the Consequences of Recombination 
Because of the extensive genetic changes achievable through recombination, the 
process can result in rapid and extreme changes in virus phenotype, including escape from 
the immune response or antiviral therapy, changes in cell or host tropism and alterations of 70 
pathogenicity. Often, recombination can go unnoticed in a virus population, but where 
events are directly linked to novel outbreaks of disease these recombination events, and 
resulting viruses, are well documented. For example, all recipients of the live-attenuated 
trivalent oral poliovirus vaccine excrete type 1/type 3 recombinants without issue within a 
week of vaccination [15, 16]. However, in regions of low vaccine coverage, recombination 75 
between polio vaccine and co-circulating type C enteroviruses has been associated with 
vaccine-derived paralysis in vaccinees or their contacts. In the first such outbreak 
characterised, the virulent viruses responsible for paralysis of Haitian children were 
sequenced and shown to consist of the Sabin 1-derived 5' non-coding region (NCR) and 
capsid-coding region, recombined with co-circulating species C enteroviruses from which 80 
the majority of the non-structural proteins and 3' NCR were derived. At least four 
independent type 1 vaccine-derived recombinant poliovirus strains were identified in this 
outbreak, all of which also carried a 5' NCR mutation known to be associated with 
neurovirulence [17].  
Subsequent prospective and retrospective studies [18-20] demonstrated how 85 
relatively frequently this type of intratypic recombination event in poliovirus could be 
observed. At the same time, epidemiological studies of circulating enterovirus species 
showed evidence for very extensive intratypic recombination [9, 21-23]. For the enterovirus 
serotypes (defined by the capsid-coding sequences to which antibodies are directed) tested 
this was characterised by the appearance, proliferation and subsequent disappearance of 90 
particular unique recombinant forms (RF) in the population. Geographic distance and time 
 influenced whether any two isolates would be the same or different RF, with increases in 
either making it more likely isolates were independent RFs. In addition, and for reasons that 
remain unclear, different serotypes exhibited different half-lives, defined as the time between 
appearance and disappearance of a particular RF [24, 25].  95 
Whilst outbreaks from polio vaccine-derived recombinants has been recognised as 
relatively frequent and is now monitored, this is not always the case and recombination often 
has unpredictable outcomes. In the alphaviruses Sindbis and Eastern Equine Encephalitis 
virus, a recombination event between the structural and non-structural ‘modules’ led to the 
emergence of Western Equine Encephalitis virus (WEE), which, although rarely causing 100 
symptomatic infections, highlights the importance of recombination in the emergence of 
novel pathogens [26]. Additionally, recombination between structural genes can also impact 
virus host range by altering receptor usage, as was the case in the emergence of SARS 
coronavirus [27] [28].  
The increasing use of whole genome sequencing clearly demonstrates the impact of 105 
recombination on virus evolution. Combined with experimental systems, recombination is 
now widely recognised as one of the most important drivers of virus evolution in positive-
strand RNA viruses. Traditionally, norovirus classification relied on sequencing of the ORF1 
polymerase region only. The rise in identification of naturally occurring recombinants 
between ORF1 and ORF2 required the inclusion of the capsid region to accurately 110 
determine the lineage of each virus [29, 30]. This additional sequencing has uncovered the 
impact of recombination in the evolution of norovirus genotypes and demonstrated a much 
higher occurrence of recombination than previously suspected [31-33]. Amongst the three 
genera of the Flaviviridae the incidence of recombination is varied, at least as determined 
by circulating recombinant forms. While experimental evidence has demonstrated frequent 115 
recombination in the pestivirus, bovine viral diarrhoea virus (BVDV), and hepacivirus, 
hepatitis C virus (HCV) [34-36], additional sequencing and phylogenetic analysis has been 
required to determine the extent of recombination in other flaviviruses. Recombination 
events are readily detected in the genomes of the mosquito-borne flaviviruses such as 
Dengue and Japanese encephalitis virus [37-40], and have been confirmed with limited 120 
experimental studies [11, 41]. In contrast, very little evidence of recombination has been 
observed for West Nile or Yellow Fever virus [40, 42], or any of the tick-borne flaviviruses 
[43-45], but has been identified when looked for. These differences may be linked to the 
arthropod vector involved in transmission, but evidence has yet to be presented to support 
this idea.  125 
 Other than the identification of WEE virus as a recombinant virus there has been 
relatively little research on the role of recombination in alphavirus evolution, or of other 
members of the Togaviridae. The propensity for alphaviruses to recombine has been 
demonstrated experimentally for Sindbis virus [46, 47] but, with the exception of 
Chikungunya virus [48, 49], no phylogenetic analyses to identify historical recombination 130 
events have been reported. Therefore, although evidence suggests recombination may be 
more prevalent in some virus families than others, recombination has been found in 
essentially all virus families where it has been looked for and is undoubtedly a ubiquitous 
characteristic of single-stranded positive-sense RNA viruses.  
Recombination may simply be an accidental by-product of virus replication, reflecting 135 
the association and dissociation of RNA template and RdRp or a process, the evolution – 
and evolutionary retention – of which provides benefit to the individual virus or the virus 
population. When comparing sexual versus asexual reproduction, an irreversible 
accumulation of detrimental mutations can severely restrict the evolution of an organism, a 
phenomenon referred to as Muller’s Ratchet [50, 51]. With their error prone polymerases 140 
RNA viruses readily mutate, and genomes can accumulate mutations to high levels. While 
some mutations are beneficial, the accumulation of deleterious mutations leads to virus 
attenuation [52]. Thus, RNA viruses would greatly benefit from evolving recombination 
mechanisms to purge these deleterious mutations, while consolidating beneficial ones. 
Evidence for such requirements has been presented in plant viruses [53] and more recently 145 
for poliovirus. In the latter, non-recombinogenic viruses – achieved by polymerase 
mutagenesis – exhibited a grossly attenuated phenotype and were unable to adapt to certain 
in vivo environments [54, 55]. These studies imply that recombination is a key adaptive 
process for survival and that the ability to recombine has been evolutionarily selected. 
However, the apparent absence of recombination in certain genera suggests that either 150 
more extensive phylogenetic studies are needed or that, although the process occurs, there 
is poorly understood functional selection that prevents their fixation in the population. To 
appreciate this better it is necessary to study the mechanistic process in more detail and to 
investigate the fate of recombinant genomes.  
 155 
Defining Recombination 
A recombinant virus may be derived following recombination events between two or 
more individual virus genomes or, as is more rarely observed, recombination between viral 
and cellular RNA. In the latter process, viral genomes are able to support the insertion of 
 cellular sequences, for example the incorporation of cellular ubiquitin-like sequences leading 160 
to the generation of cytopathogenic strains of BVDV [56, 57]. However, in this article we will 
focus on the more general process of recombination between virus genomes as recent 
studies have provided insights into the underlying mechanisms and selection processes that 
operate.  
Many naturally occurring and laboratory-generated recombinants have been 165 
characterised from different virus families. To date, two fundamentally distinct mechanisms 
of recombination have been proposed. It should be noted that, for naturally isolated 
recombinants, the mechanism of generation cannot be determined as the end products are 
essentially indistinguishable. For convenience, and reflecting the role of parental genome 
replication, these mechanisms are referred to as replicative and non-replicative 170 
recombination. Perhaps reflecting the historically better-studied process of DNA 
recombination [58] or a presumption of the underlying mechanism by which they are 
generated, many studies use the terms homologous and non-homologous to describe the 
features of the recombinant virus and, more specifically, the recombination junction. 
Homologous is used to refer to recombinant junctions in which the parental genomes exhibit 175 
a wide degree of sequence identity at that position, perhaps not altogether unsurprising in 
closely related viruses. In contrast, non-homologous recombination refers to junctions, or 
the process, in which the genetic crossover occurs between poorly conserved regions or 
unrelated RNA molecules. Additionally, ‘aberrant homologous recombination’ is also used 
to describe recombination between similar genomes in dissimilar locations. More recently, 180 
in light of our studies on the molecular mechanism of recombination ([59], and see below) 
we introduced the term ‘precise’ to indicate a recombination crossover that exists at the 
same position in two related parental genomes, and ‘imprecise’ to indicate a junction that 
maps to two different locations in the parental genomes (whether related or not) (Fig. 1a). 
This nomenclature has the advantage of not implying anything about the underlying process 185 
by which recombinants are generated. 
To generate a recombinant virus several principles must be observed. Firstly, a cell 
must contain two or more viral genomes. Depending on the process these genomes may or 
may not need to be replication competent (discussed below) but they must be able to 
physically interact within the cell, and so cannot occupy separate replication complexes or 190 
cellular compartments. Secondly, the recombination event must generate a viable genome 
that is able to replicate and can be packaged into infectious progeny virions. In addition, the 
resulting virus must be able to survive in competition within a mixed virus population, 
 although certain transmission routes via a limited inocula, such as in aerosol droplets or by 
dilution in faecal-contaminated water, may provide sufficient population bottlenecks in which 195 
less fit recombinants can proliferate. For recombination between virus genomes of the same 
species these principles are generally easily met but may explain the lack of recombination 
observed between viruses of different species and genera.  
The Enterovirus genera of the Picornaviridae family consists of 15 species in total, 
and while intraspecies recombination is common [17, 60], significant interspecies 200 
recombination has not been noted in nature. The assumption here would be that either 
viruses of different species replicate in separate replication complexes and thus do not have 
the opportunity to recombine, that recombinant genomes are not viable due to protein-
protein or protein-RNA incompatibility, or that recombinants that do arise are insufficiently 
fit to compete in the environment. The plasticity of the enterovirus 5' NCR has been 205 
previously demonstrated through generation of artificial genomes [61, 62] and it is only within 
this region that any interspecies recombination has been observed, both by in vitro 
generation, and natural isolation, of recombinant viruses [63, 64]. Importantly, by isolating 
interspecies recombinants, these studies suggest that viruses of different enterovirus 
species do in fact interact during replication, presumably within the same replication 210 
complexes. Interestingly, evidence for inter-family recombination has also been shown with 
the recent identification of a novel enterovirus circulating in pigs that contains a papain-like 
protease with high similarity to that of the toroviruses [65-68] although the source and 
mechanism of acquisition of these sequences remains unclear. The viability and fitness of 
recombinants is therefore much more likely to explain why recombination is so rarely 215 
observed in nature for some viruses. 
A key aspect in the generation of viable recombinant viruses is the modular nature of 
positive-sense single-stranded RNA genomes [9]. Generally, the 5' and 3' termini (non-
coding region; NCR) are untranslated and contain sequences and RNA structures 
implicated in the replication of the genome and the expression of the viral proteins. The 220 
remainder of the genome encodes a polyprotein in which the structural and non-structural 
(respectively, those found in the mature virus particle and those that are produced from the 
genome but not packaged) coding regions are distinct, but not necessarily separate. Recent 
metagenomic analysis has demonstrated that the apparent modularity of the genome 
remains a fundamental characteristic [69]. Whilst this organisation undoubtedly reflects the 225 
evolutionary origins of virus families, it also contributes significantly to the process of 
 recombination by the exchange or acquisition of complete, or near-complete, ‘modules’ via 
a single genetic crossover. Mechanistically, how do these crossover events occur? 
   
How do Viruses Recombine? 230 
Replicative Recombination 
Genetic recombination in RNA viruses was first identified in the 1960’s from the study 
of poliovirus and, although recombination was readily detected [7, 8, 70, 71], at this time, it 
was not clear whether recombinants were generated through a DNA-like break-repair 
mechanism, or through a form of copy-choice, as first proposed by Cooper et al. in 1974 [6]. 235 
It is now generally accepted that the primary source of recombination is via a replicative 
process involving a copy-choice mechanism where the viral polymerase switches from one 
genome to another during negative-strand RNA synthesis [72]. Further progress in 
determining the mechanisms behind replicative recombination has been slow, in part due to 
the relatively rare nature of recombination events. The infrequent generation of viable 240 
recombinant viruses has meant that, until the widespread use of sequencing, only those 
able to propagate and become established in a virus population could be isolated or 
detected. As a result, recombinant genomes are difficult to isolate from the overwhelming 
majority of parental genomes generated during replication. To overcome the difficulty of 
isolating recombinant viruses, early studies with poliovirus utilised co-transfection of cells 245 
with viral RNAs, each with a different selective genetic marker, such as a temperature 
sensitive mutation, or resistance to guanidine [6, 7, 72]. Under selective conditions only 
those genomes that have undergone a recombination event will be permissive for growth 
and can therefore be isolated and analysed. Similar techniques have also been used to 
determine the rate of recombination in the coronaviruses [10, 73, 74]. More recently a 250 
number of assays have utilised retention of marker genes such as GFP, expressed from the 
virus genome, to investigate recombination events in poliovirus and flaviviruses [11, 55]. 
However, the loss of genetic sequences is, semantically, an in cis event and may not 
properly reflect the process of recombination which is, by definition, an in trans event 
involving two genomes.  255 
 
CRE-REP and Biochemical Assays 
To address the need for robust assays to study recombination we have recently 
developed a cell-based approach known as the CRE-REP assay using poliovirus [59]. The 
 only viable progeny viruses produced in this assay are recombinants, so facilitating their 260 
characterisation. The assay exploits the co-transfection of two compromised RNA genomes 
that individually cannot generate viable infectious virus, but that will yield viable progeny 
virus following a successful recombination event (Fig. 1b). The first RNA partner is a 
poliovirus sub-genomic replicon in which the structural genes have been replaced with a 
reporter gene, in this case firefly luciferase. Designated the donor, this RNA is fully 265 
replication competent but cannot form infectious particles due to the absence of the capsid-
coding region. The second RNA partner, the acceptor, contains a cluster of well-
characterised point mutations [75, 76] within the cis-replicating element (CRE) located within 
the 2C-coding region. These mutations disrupt the CRE, inhibiting the uridylyation of VPg 
and consequently preventing positive-strand synthesis [76-78]. Therefore, although this 270 
acceptor RNA can be translated and produce negative-strand RNAs it is also unable to 
generate infectious progeny virus. The designation of donor and acceptor reflects the origin 
of the polymerase in the resulting recombinants. In single crossover recombinants this is 
derived from the sub-genomic replicon and occurs from a negative-strand copy-choice 
recombination event.  275 
In the CRE-REP assay viable recombinants must involve a strand-transfer event 
located between the functional CRE in the sub-genomic replicon and the junction between 
the structural and non-structural coding regions of the polyprotein. Hybrids that form outwith 
these regions would, by definition, lack essential components of the genome. To provide a 
larger region for recombination we have recently demonstrated that a sub-genomic replicon 280 
with the functional CRE re-located to the 3' NCR also functions as a donor template, 
increases the yield of recombinants and allows recombinants to be isolated throughout the 
region encoding the non-structural proteins [79]. To facilitate the isolation of early 
recombinants a cell monolayer permissive for poliovirus replication, but not susceptible to 
infection, is used. Murine or hamster cells that lack the poliovirus receptor are co-transfected 285 
but cannot be subsequently infected by any progeny recombinant viruses. These remain in 
the supernatant for analysis. Using this assay, we are able to capture recombinants soon 
after their generation and before they have undergone additional rounds of genome 
replication. 
To our surprise the majority of these early recombinants were found to be greater-290 
than genome length and contained sequence duplications at the site of the recombination 
junction (Fig. 1b). We designated these imprecise recombinants; since their mechanism of 
generation was unclear we considered that the term aberrant homologous recombinants – 
 used in some previous studies to describe similar genomes – which implied that sequence 
homology was a contributor to their production, was misleading. Where duplications were 295 
present, the junctions preferentially straddled the encoded proteolytic cleavage sites in the 
poliovirus polyprotein. This suggested a selective mechanism whereby recombinants able 
to encode one non-chimeric copy of a full complement of polyprotein products had a growth 
advantage. Subsequent studies demonstrated that repeated passaging of the majority of 
imprecise recombinants results in the deletion of genome duplications and the isolation of 300 
recombinants of the correct genome length (which we designated precise recombinants). 
While this type of imprecise recombinant genome had not been reported in naturally-isolated 
recombinant enteroviruses, these results were consistent with those subsequently observed 
from a different poliovirus and coxsackievirus model system [80]. Interestingly, similar 
recombinants containing sequence duplications have been observed from in vivo samples 305 
of a BVDV infected animal, seemingly following an initial recombination event with cellular 
RNA sequences, confirming generation of imprecise recombinants may be a natural step of 
the recombination process [81]. We proposed that recombination is a biphasic process 
consisting of an initial, predominantly imprecise, strand-transfer event with selection for 
replication-competence and the ability to form an infectious virus particle. This is followed 310 
by a secondary “resolution” event that – as a consequence of selecting viruses with 
increased fitness – deletes the genome duplications present in the primary recombinant. 
Additional evidence for this biphasic recombination process may come from future NGS 
analysis of recombinant RNA products in co-infected or -transfected cells, or analysis of 
resolving recombinant virus populations. 315 
The contribution of the viral polymerase to recombination was studied directly using 
a defined in vitro biochemical assay [79]. The RdRp was shown to be necessary and 
sufficient for catalysing the initial copy-choice template switching event. A growing body of 
evidence has shown that recombination is intrinsically linked to polymerase activity, with 
mutations that are known to affect the fidelity of the enzyme directly influencing the rate of 320 
recombination between genomes [55, 59, 82, 83]. High fidelity mutants of the poliovirus 
polymerase, such as a well characterised G64S mutant [84], demonstrate a reduced 
capacity for recombination compared to wild type levels [59]. These high-fidelity polymerase 
variants are contenders for inclusion in future non-recombinogenic live attenuated vaccines. 
In contrast, low fidelity mutants or the addition of sub-lethal levels of ribavirin, an antiviral 325 
known to increase the poliovirus polymerase error rate, results in increased yields of 
recombinant viruses [59, 79]. Mechanistically it remains to be determined how changes in 
fidelity influence the strand-transfer event. One possibility is that this may be due to 
 misincorporation leading to polymerase pausing or template dissociation [85]. Although the 
biochemically-defined in vitro recombination assay [79] demonstrates that the polymerase 330 
alone is necessary and sufficient to catalyse strand-transfer, there is some evidence that 
other features of the virus genome contribute to the process of recombination. For example, 
a chaperone-like activity of the poliovirus 3AB protein may assist in recombination via helix-
destabilisation and promotion of RNA annealing between the two parental genomes at the 
site of the polymerase strand-transfer [86], in a similar manner to the enhancement of 335 
recombination by the nucleocapsid protein of HIV [87, 88].  
 
RNA Structure and Sequence Influences on Recombination 
Many studies have focused on the characteristics of the junction between parental 
genomes in naturally or experimentally isolated recombinants, in particular inferring 340 
involvement for RNA secondary structures and sequence motifs in the process. For 
example, the presence of RNA structures, such as hairpin loops, has been linked to the 
promotion of recombination hotspots in a number of plant viruses within the Tombusviridae 
[89-91]. One suggestion is that hairpin and stem-loop type structures, when present in the 
donor RNA, will promote the dissociation of the polymerase so initiating a crossover event. 345 
Structures present in the acceptor RNA may also influence where the polymerase will re-
initiate transcription, with sites upstream of hairpins seemingly favoured to prevent repeated 
dissociation of the polymerase [89]. Conflicting evidence has been presented however for a 
different plant virus, Brome mosaic virus (BMV). The tri-partite genome of BMV has been 
shown to readily undergo both homologous and non-homologous recombination (precise 350 
and imprecise respectively using our terminology) between its three RNA components [92, 
93]. In one report a specific hairpin structure in RNA3 was found to correlate with the 
occurrence of non-homologous crossovers in a site-specific manner [94], while an earlier 
study found no evidence for a role of secondary structures [95]. Similarly, a positive 
correlation between the presence of RNA structures and recombination hotspots has also 355 
been identified for members of the Flaviviridae [41], the Coronaviridae [96] and poliovirus. 
In the latter, Runckel et al. [97] used NGS to analyse the recombinant progeny between 
poliovirus genomes bearing numerous translationally-silent genetic tags. In this study they 
observed increased recombination frequency in regions of localised RNA structure in the 
largely unstructured genome [98]. 360 
However, in analysis of a limited number of recombinant progeny generated in the 
CRE-REP assay [59] no such link between RNA structure and the recombination junction – 
 either before or after resolution – could be demonstrated. Furthermore, if the biphasic nature 
of the process of recombination is generally applicable, the junctions in the chimeric 
genomes characterised in all previous studies result from fitness selection occurring during 365 
the resolution event, rather than recombination per se. To address this directly, we have 
recently investigated recombination between templates engineered to significantly increase 
or decrease the gross level of RNA structure and show that this did not influence the location 
of primary or resolved junctions (Bentley et al., in preparation).  
It is clear that further research is required in this area to fully establish if and how 370 
RNA secondary structure influences recombination, and if so, whether this is a universal 
mechanism of control, or differs between virus families. 
Less well studied has been the role of the RNA sequences per se in influencing 
recombination, either as homology (identity) between templates, or as particular sequences 
that mediate polymerase dissociation and/or re-association. Several studies have reported 375 
that the distribution of recombination junctions is biased towards regions of sequence 
identity between RNA templates [89, 94, 95, 99]. These regions are predicted to be involved 
in heteroduplex formation between templates, so facilitating polymerase template switching. 
In agreement with this, the extent of sequence homology is reported to positively influence 
recombination frequency [95, 100]. However, the majority of these studies pre-date 380 
evidence for a biphasic recombination mechanism, so may instead reflect a role for 
sequence identity in an in cis resolution event, a conclusion in agreement with the influence 
of flanking sequences on reporter gene retention [55]. In our studies of poliovirus, intertypic 
recombination is less frequent that intratypic, suggesting a positive influence of sequence 
identity on recombination. However, analysis of intratypic recombinants, where there are 385 
regions of limited sequence identity, show no correlation between these regions and the 
recombination junctions [59, 72].  
The nucleotide composition of recombining RNA templates has also been linked to 
recombination frequencies, with contradictory evidence again presented for viruses of 
different families. For BMV, AU rich regions were found to be associated with recombination 390 
hotspots, while altering the nucleotide composition to create GC rich regions was associated 
with a suppression of recombination [101-103]. This was also found to be the case for the 
pestivirus BVDV [104]. In contrast, GC rich regions are reported to be associated with a 
higher frequency of recombination in poliovirus [97].  
It may be that the influence of structure or sequence on recombination varies between 395 
viruses and is likely influenced by the methods used to define, 
 recombinants. Developing techniques and methodologies to investigate precisely how the 
polymerase interacts with structural and sequence motifs before, and during, the template 
switching event will be crucial to unravelling the currently mixed evidence of the influence of 
the RNA template(s) on replicative recombination.    400 
 
Non-replicative Recombination 
 Non-replicative recombination was first proposed as a mechanism distinct from that 
of the copy-choice mediated replicative process from studies of bacteriophage Qß [105]. In 
these, recombinants are generated in vitro – following co-transfection – from overlapping 405 
fragments of viral RNA that are individually deficient in their ability to replicate; for example, 
a 5' partner with the polymerase-encoding gene and the 3' NCR deleted and a 3' partner 
with deletion of the 5' NCR (Fig. 1c). Those sequences missing from the 5' partner are found 
in the 3' partner and vice versa and, upon co-transfection into cells, these partial genomes 
can generate viable progeny virus if they can be suitably joined together with a 410 
phosphodiester bond. In early studies of this process the inclusion of an intact Qß replicase 
coding region in the reactions meant that replicative recombination could not be ruled out 
entirely. However, the identification of recombinants that could only be generated in an end-
to-end joining type reaction led to speculation of an alternative mechanism. Subsequently, 
this mechanism was confirmed for poliovirus, BVDV and HCV [34-36, 106-108]. More recent 415 
studies have demonstrated that neither the 5' or 3' components that undergo non-replicative 
recombination apparently need to be translated, strongly implying that viral proteins are not 
involved in the process [108].  
While non-replicative recombination is arguably a cleaner system with which to 
generate recombinant viruses for study in vitro, the biological significance of this process, 420 
and its contribution to recombinant yields in vivo, is more difficult to establish. In our own 
studies, using equivalent amounts of RNA in transfections, we have reported that viable 
progeny from a proven replicative process are ~25x more frequently generated [59]. More 
recently, by considerable optimisation of the transfection conditions used, we can generate 
equivalently high yields of recombinant poliovirus by both replicative and non-replicative 425 
mechanisms, in the range of 2x104 PFU/ml per Pg of transfected RNA (Bentley, 
unpublished). This implies that the efficiency or frequency of the two processes may be 
similar. However, the highly artificial nature of these assays – essentially co-transfection of 
thousands of copies of in vitro synthesised RNA per cell – means that these comparisons 
are only of relevance under experimental conditions. In reality, only if the 5' and 3' partner 430 
 RNAs utilised in vitro reflect products naturally generated during virus infection will a non-
replicative process be relevant to the evolution of viruses observed in nature. In addition, as 
the end products of both the replicative and non-replicative mechanisms are potentially the 
same, the origin of recombinants is impossible to determine and therefore the relative 
importance of replicative and non-replicative recombination remains unclear.  435 
 The mechanisms behind non-replicative recombination have been less well studied 
than those of replicative recombination. Conflicting evidence has been presented regarding 
the types of end modification needed on the 5' and 3' partner RNAs in order to facilitate end-
to-end joining. Chetverin et al. found that the 5' partner RNA required a 3' hydroxyl group for 
efficient recombination in bacteriophage Qß [105], postulating a mechanism by which, 440 
following a covalent interaction of the two RNAs, the 3' hydroxyl group attacks a phosphate 
group in the sugar backbone of the 3' partner RNA resulting in a ligation of the two RNAs 
similar to that observed in splicing events. This process required the presence of the Qß 
RdRp however, suggesting that the majority of recombinants were derived using a 
replicative process. In a poliovirus system lacking all replicative ability, the opposite result 445 
was observed with oxidation of the 3' end of the 5' partner increasing rather than decreasing 
the number of recombinants [107]. For BVDV, RNA molecules with 3' mono-phosphoryl and 
5' hydroxyl ends were found to generate significantly higher yields of recombinants [35]. As 
these ends represent those generated following endoribonuclease-based cleavage, it was 
postulated that such cleavage events and a subsequent ligation reaction may provide the 450 
basis of a non-replicative recombination mechanism. This would imply a substantial or 
absolute requirement for host-cell proteins in the non-replicative mechanism, a conclusion 
supported by the observation that viral proteins are not required for this process [36, 108]. 
This is in marked contrast to our current understanding of the replicative recombination 
process, which has an absolute requirement for, and is grossly influenced by, the viral RdRp. 455 
This leads to the broader question of the involvement of host proteins in the recombination 
process, whether replicative or not. 
 
Host Factors in Recombination 
 RNA viruses rely heavily on a variety of host cell factors for their replication (reviewed 460 
in [109] and [110]) but the subversion of host proteins for recombination remains little 
explored. Host cell factors may be directly required for recombination, as is likely the case 
for the non-replicative mechanism. In contrast, although it has been demonstrated for 
replicative recombination that the polymerase alone is sufficient for the strand-transfer 
 events [79], this does not exclude modulatory roles for either host or other viral proteins. At 465 
the forefront of research in this area has been the study of tombusvirus recombination [111]. 
One advantage of studying tombusviruses is their ability to replicate [112] and recombine in 
yeast. This has allowed for the large scale genetic screening of host factors that may be 
involved in recombination [113]. From these screens a number of host genes, many involved 
in RNA degradation pathways, have been identified that suppress viral recombination. The 470 
5' to 3' exoribonuclease Xrn1 is a key component of the mRNA degradation pathway and 
has been implicated in recombination, in both yeast and plant model systems, as a regulator 
of the RNA substrates that are available for recombination [114, 115]. A mechanism was 
proposed in which viral RNAs are first cleaved by a host endoribonuclease, Ngl2p, to 
generate 5' and 3' RNA fragments. In the presence of Xrn1 the 3' fragments are rapidly 475 
degraded such that they are no longer available to participate in the end-to-end joining 
mechanism commonly observed for recombination in tombusviruses. This mechanism is 
presumed to be non-replicative and further genetic screening may enable the identification 
of the cellular ligase that may also be implicated in the process. 
The pathways involved in Xrn1-mediated suppression of recombination may be 480 
complex and indirectly regulated by additional host factors. Xrn1 activity was found to be 
inhibited by pAp, the substrate for yeast (MET22) and plant (AHL, SAL1 and FRY1) 
nucleotidases. Deletion, or ‘knockdown’ of the nucleotidase lead to increased substrate 
inhibition of Xrn1, suppressing viral RNA degradation and thus increasing the observed yield 
of recombinants [116]. Although the authors of these studies suggest that the assays used 485 
measure the results of replicative recombination, the RNA fragments generated by the 
activity of host endoribonucleases such as Ngl2p [114], or MRP [117], are highly similar to 
the RNA fragments utilised in cell-based non-replicative recombination assays, and possibly 
highlight the first stage in the generation of non-replicative recombinants. How such 
fragments are ligated in the in vitro assays remains elusive, but further research into the role 490 
of Xrn1, and host endoribonucleases, may help shed light on the as yet undefined 
mechanism of non-replicative recombination.  
 
Recombination, Defective RNAs, Defective Interfering RNAs and Resolution 
A common attribute of virus replication for many RNA viruses, including those with 495 
positive strand genomes, is the generation of defective (D), and defective-interfering (DI) 
RNAs [118-120]. Both lack partial genome sequences – usually regions encoding the 
structural proteins – whilst retaining the sequences and signals required for replication (Fig. 
 1a). Defective genomes can therefore replicate, some can be encapsidated into capsids 
provided in trans and those termed ‘interfering’ can effectively compete with full-length 500 
genomes, reducing the yield of viable progeny by usurping replication proteins or capsids. 
Structurally-similar engineered sub-genomic replicons, in which the capsid protein coding 
regions are replaced with a reporter gene, have been useful tools to study RNA virus 
replication and packaging [121, 122], but are generally unable to interfere.  
The generation of D-RNAs and DI-RNAs has been far more extensively studied for 505 
the negative-strand viruses where it has been shown to occur by several means, including 
via a copy-choice mechanism [123], thus forging a parallel with the generation of 
recombinant viruses. In theory, D/DI-RNAs could be generated by an imprecise 
recombination event leading to a sequence deletion, as opposed to the insertions often 
observed with recombinants generated via the CRE-REP assay. Mechanistically these are 510 
analogous events, with the biased output of the CRE-REP assay simply reflecting the 
absolute requirement for the production of infectious virus particles. While a link between 
recombination and the generation of DI-RNAs has been postulated for many years, little 
evidence has been presented to demonstrate a direct link and determine whether DI-RNA 
generation occurs intra- or inter molecularly. By using cloned cDNAs of naturally occurring 515 
DI-RNAs from the closely related corona- and arteriviruses there is evidence to show that 
recombination can occur between a DI and its helper virus [124, 125]. Although this does 
not prove that DI-RNA and recombinant generation utilise the same mechanism, it does 
suggest that recombination may be a mechanism by which DI-RNA’s evolve and are 
maintained in the virus population. Strong evidence for a link between recombination and 520 
DI-RNA generation has been shown for alphaviruses however, using Sindbis virus [83]. 
Using a mutator strain of the virus Poirier et al. demonstrated that an increased polymerase 
error rate was linked to an increase in the recombination rate and that this led to a higher 
rate of accumulation of DI-RNA’s. Again, while this does not prove that DI-RNA’s are 
generated via the same mechanism as recombinants, the two processes are clearly 525 
interlinked. Future research into the mechanisms underlying DI-RNA and recombinant 
generation may provide interesting insights into how closely related these processes are. 
Finally, analysis of the process of resolution – at its simplest an in cis deletion of duplicated 
sequences acquired during an imprecise recombination event – may demonstrate it is 
mechanistically identical to the generation of DI genomes.  530 
 
The Future of Recombination Research 
  There is still much to discover about recombination in RNA viruses, both in terms of 
the mechanism and how it relates to virus evolution. With an improved understanding of the 
mechanisms we may be able to better predict how and where recombinant viruses will arise 535 
and be better prepared for the potential consequences. Although the polymerase has been 
shown to be sufficient for replicative recombination, a number of aspects of its activity still 
need to be investigated. A point of particular interest is the relationship between polymerase 
fidelity, misincorporations, and recombination. Are polymerases that introduce mutations at 
a higher rate more likely to induce recombination simply due to an increased rate of 540 
dissociation and re-association between the template and the enzyme? Alternatively, is 
there a more intricate relationship in the relative contributions of recombination and 
mutations in the generation of quasispecies necessary for escaping population bottlenecks? 
In addition, the polymerases of many RNA viruses oligomerise to form higher order 
structures [126-128]. Do such structures have a role in recombination by influencing the 545 
interaction of the enzyme with the RNA templates? In the latter, the role of localised RNA 
structures in promoting recombination remains unclear. More extensive, longer range or 
higher order RNA structures, such as genome cyclization [129] or genome-scale ordered 
RNA structure [98], may have as yet unidentified importance in recombination or resolution.   
With the exception of an essential contribution of the RdRp to replicative 550 
recombination, roles for additional viral or cellular proteins in the process remain unclear. If 
requirements do differ between related viruses it may explain the apparent restrictions in 
recombination observed. Specificity determined by intracellular components could also 
extend to include the compartmentalisation of the virus genome in replication complexes 
(logically only in replicative recombination). We and others have demonstrated that 555 
recombination is reduced by nocodazole [59, 130], an inhibitor of microtubule polymerisation 
and consequent coalescence of replication complexes. Even two closely related viruses, 
occupying replication complexes derived from different membrane compartments, may 
never get the opportunity to meet and recombine. 
As with other areas of virology, the ability to interrogate the entire RNA population 560 
using deep sequencing strategies will provide important insights into recombination and 
resolution. Is the initial recombination (crossover) event truly promiscuous, with no 
sequence specificity and a random distribution throughout both parental genomes? 
Similarly, what determines the intermediates and the final products of resolution? Is it solely 
the functionality and fitness of the resulting virus? A better understanding of these processes 565 
will help us comprehend this fundamental evolutionary mechanism. Additionally, by 
 understanding what leads to the selection of particular recombinants over the countless 
number that could be generated, we will gain important insights into the functionality of the 
encoded viral proteins, their interactions with each other and with those of the host.  
 570 
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Figure Legend 870 
 
Fig.1. Recombinant single-stranded positive-sense RNA viruses, their nomenclature 
and generation. Schematic genomes are representative of poliovirus, the prototype 
enterovirus, with numbering of the proteins within by the polyprotein; 1-4 are the structural 
proteins (VP4, 2, 3 and 1), 5-11 are the non-structural proteins (2Apro, 2B, 2C, 3A, 3B[VPg], 875 
3Cpro, 3Dpol), with primed numbers indicating partial or incomplete protein coding regions.  
(a) Co-infection of cells with two viruses (represented by Genome 1 and Genome 2) may 
result in a number of replication-competent genomes. Precise recombinants are parental-
length with a junction and no extraneous sequences. Imprecise recombinants contain 
duplications at the crossover region. For convenience we have omitted the potential 880 
reciprocal products with Genome 2 forming the 5' end of the progeny. Defective RNA 
genomes contain an in cis deletion, typically within the capsid-coding region. Single 
crossover events are only shown, though we and others have detected double crossovers 
in natural and experimentally generated recombinants. (b) The CRE-REP assay. The 
Acceptor genome (blue) bears a well-defined modification of the essential cis-replicating 885 
element (CRE) in the 2C coding region that prevents positive-strand synthesis. The Donor 
genome (red; so-called because the polymerase in the progeny is derived from this parental 
genome) has the capsid-coding sequences replaced with a reporter gene (Luc). Donor and 
Acceptor RNA are transfected into permissive cells and undergo recombination during 
negative strand synthesis to generate imprecise recombinants. Subsequent rounds of 890 
replication, within the original cell or upon serial passage in uninfected cells, leads to 
resolution resulting in the loss of the genome duplications within the imprecise recombinant. 
(c) Non-replicative recombination assay. Donor (red) and Acceptor (blue) partner RNAs are 
generated in vitro by truncation of the 3' or 5' ends, respectively of the parental virus genome. 
 Co-transfected RNAs are presumed to be processed by host endo- and exonucleases and 895 
subsequently ligated by host RNA ligases. The initial product, an imprecise recombinant – 
if replication-competent – can undergo subsequent resolution in which duplicated 
sequences within the genome are lost.  
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